Results 111 to 120 of about 302,595 (156)

Sex Transm Dis

We compared mpox vaccination access between urban and rural residents who received 651 JYNNEOS dose using immunization data in Idaho and New Mexico.

core  

Evidence to recommendations framework : vaccination with JYNNEOS during Mpox outbreaks [PDF]

Mpox-07-Rao-508 ...

core  

Vaxxing to elimination: smallpox vaccines as tools to fight mpox

Journal of Clinical Investigation, 2023
Boghuma K. Titanji, Vincent C. Marconi
openaire   +3 more sources

Mpox: Global outbreaks, vaccination, and ongoing challenges

Journal of the Formosan Medical Association
Chun-Yuan Chen, Yin-Chien Lin, Chi-Tai Fang   +2 more
openaire   +2 more sources

The MPOX Vaccine Landscape: A Critical Assessment

Medical Journal of Dr. D.Y. Patil Vidyapeeth
Isha Sangtani, Shahzad Mirza
openaire   +1 more source

The perspectives and knowledge of patients with cancer on mpox and mpox vaccination: a cross-sectional study

Current Medical Research and Opinion
The recent outbreak of monkeypox (mpox) poses significant public health challenges, particularly for immunocompromised populations such as patients with cancer. However, misinformation poses a significant challenge during new outbreaks for patients with chronic diseases, as observed during the COVID-19 pandemic.
Taha Koray Sahin, Yunus Kaygusuz, Mehmet Cihan İcli, Sercan Aksoy, Deniz Can Guven   +4 more
openaire   +4 more sources

Knowledge of Human Mpox (Monkeypox) and Attitude Towards Mpox Vaccination Among Male Sex Workers in China: A Cross-Sectional Study

Vaccines, 2023
Background: Re-emerging human mpox (previously known as monkeypox) is spreading around the world. According to existing studies, the current mpox pandemic mainly affects men who have sex with men (MSM), including male sex workers (MSW).
Hongbo Jiang, Bingyi Wang, Huachun Zou
exaly   +2 more sources

Some of the next articles are maybe not open access.

Related searches:

JYNNEOS Vaccine for Mpox

JAMA, 2023
This JAMA Patient Page describes the eligibility, safety and effectiveness, and administration procedure for the JYNNEOS vaccine for mpox infection.
Angel N. Desai, Preeti N. Malani
openaire   +1 more source

Monkeypox (Mpox) Vaccine Hesitancy Among Mpox Cases: A Qualitative Study

Health Promotion Practice, 2023
Human mpox has been an increasing concern in the United States and California since late 2022. While the Jynneos vaccine offers a degree of cross-protection against the disease, vaccine hesitancy is common among those recommended for vaccination. The purpose of this study was to assess vaccine knowledge, facilitators, and barriers to vaccine uptake ...
Harit Agroia, Emily Smith, Akanksha Vaidya, Sarah Rudman, Monika Roy   +4 more
openaire   +3 more sources

Predicting vaccine effectiveness in Mpox

2023
Abstract The Modified Vaccinia Ankara vaccine developed by Bavarian Nordic (MVA-BN) was widely deployed to prevent Mpox during the 2022 global outbreak. This vaccine was initially approved for Mpox based on its reported immunogenicity and effectiveness in animal models, rather than evidence of clinical efficacy.
Matthew T. Berry, Shanchita R. Khan, Timothy E. Schlub, Adriana Notaras, Mohana Kunasekaran, Andrew E. Grulich, C Raina MacIntyre, Miles P. Davenport, David S. Khoury   +8 more
openaire   +1 more source